A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

Study Summary

The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 1 diabetes (T1D) will be treated with insulin icodec as prescribed to by their doctor, in accordance with usual clinical practice. This study will last for about 22 to 30 weeks.

Conditions

Diabetes Mellitus, Type 1

Interventions / Drugs

Insulin icodec

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment245 participants

Primary Completion—

Lead SponsorNovo Nordisk A/S

Data Retrieved2026-04-11 02:55:47.366779+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.